BHC
NYSE · Pharmaceuticals
Bausch Health Cos Inc
$5.08
+0.09 (+1.80%)
Performance
1D
—
1W
—
1M
—
3M
-29.44%
6M
-21.48%
1Y
-25.40%
YTD
-29.54%
Open$5.07
Previous Close$4.99
Day High$5.22
Day Low$5.05
52W High$11.97
52W Low$5.91
Volume—
Avg Volume638.5K
Market Cap2.85B
P/E Ratio13.30
EPS$0.42
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$6.64
Below
SMA 200
$6.36
Below
RSI (14)
60
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
9 analysts
Price Target
+1,942.9% upside
Current
$5.08
$5.08
Target
$103.78
$103.78
$65.08
$103.78 avg
$115.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.40B | 12.40B | 415.01M |
| Net Income | 205.01M | 170.66M | 120.28M |
| Profit Margin | 1.5% | 1.5% | 29.0% |
| EBITDA | 3.89B | 3.41B | 156.90M |
| Free Cash Flow | — | — | 115.51M |
| Rev Growth | +8.1% | +8.1% | +10.0% |
| Debt/Equity | 44.72 | 44.72 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |